A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Rheumatoid arthritis (RA) is strongly associated with the human leukocyte antigen (HLA)-DRB1 locus that possesses the shared susceptibility epitope (SE) and the citrullination of self-antigens. We show how citrullinated aggrecan and vimentin epitopes bind to HLA-DRB1*04:01/04. Citrulline was accommodated within the electropositive P4 pocket of HLA-DRB1*04:01/04, whereas the electronegative P4 pocket of the RA-resistant HLA-DRB1*04:02 allomorph interacted with arginine or citrulline-containing epitopes. Peptide elution studies revealed P4 arginine–containing peptides from HLA-DRB1*04:02, but not from HLA-DRB1*04:01/04. Citrullination altered protease susceptibility of vimentin, thereby generating self-epitopes that are presented to T cells in HLA-DRB1*04:01+ individuals. Using HLA-II tetramers, we observed citrullinated vimentin- and aggrecan-specific CD4+ T cells in the peripheral blood of HLA-DRB1*04:01+ RA-affected and healthy individuals. In RA patients, autoreactive T cell numbers correlated with disease activity and were deficient in regulatory T cells relative to healthy individuals. These findings reshape our understanding of the association between citrullination, the HLA-DRB1 locus, and T cell autoreactivity in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., Gabriel, S., Hirsch, R., Hochberg, M. C., Hunder, G. G., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23176 · Cited by 5,499
Gregersen, P. K., Silver, J., & Winchester, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,599 · cited 3×
“Alleles having this shared conserved region of the DR 70–74 region are termed to have a shared susceptibility epitope (SE; Gregersen et al., 1987) and include the commonly occurring HLA DRB1*04:01, *04:04, and *01:01 molecules.”
BackgroundInfluentialMiyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291 · cited 2×
“…and activated CD45RAFoxp3+CD25hi suppressive populations (regulatory T [T reg] cells), and Foxp3loCD45RA and Foxp3-CD45RA+ and CD45RA nonsuppressive populations, which each have potential for proinflammatory cytokine production upon stimulation ex vivo (Miyara et al., 2009, 2011).”
BackgroundEstimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
Helmick, C. G., Felson, D. T., Lawrence, R. C., Gabriel, S., Hirsch, R., Kwoh, C. K., Liang, M. H., Kremers, H. M., Mayes, M. D., Merkel, P. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23177 · Cited by 2,058
Raychaudhuri, S., Sandor, C., Stahl, E. A., Freudenberg, J., Lee, H.-S., Jia, X., Alfredsson, L., Padyukov, L., Klareskog, L., Worthington, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.1076 · Cited by 946 · cited 4×
“1.6 1.9 2.1 1.3 1 1.8 1.8 aRp.i.m = hkl [1/(N 1)]1/2 i | Ihkl, i <Ihkl> | / hkl <Ihkl> bRfactor = ( | |Fo| |Fc|”
BackgroundInfluentialKlareskog, L., Catrina, A. I., & Paget, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60008-8 · Cited by 787
A time- and cost-efficient system for high-level protein production in mammalian cells
Aricescu, A. R., Lu, W., & Jones, E. Y. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906029799 · Cited by 762 · cited 2×
“The extracellular domains of the HLA-DR4 (DRA*01:01/DRB1*04:01, *04:02, and *04:04) and chains were cloned into the pHLsec (Aricescu et al., 2006) vector for expression in HEK 293S (GnTI) cells (Reeves et al., 2002).”
MethodImproved visualization of protein consensus sequences by iceLogo
Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J., & Gevaert, K. (2009) · Nature Methods · doi:10.1038/nmeth1109-786 · Cited by 741
Cited by
Items 201–300 of 505
Maseda, D., Bonami, R. H., & Crofford, L. J. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.907744 · Cited by 25
“They showed that citrullinated aggrecan and vimentin epitopes bind to HLADRB1* 04:01/04 [36] by identifying larger numbers of recirculating tetramer-specific T cells in RA patients compared with healthy individuals.”
BackgroundAnderson, K. M., Roark, C. L., Portas, M. A., Aubrey, M. T., Rosloniec, E. F., & Freed, B. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39636 · Cited by 25
“However, Scally et al (19) reported that citrullinated vimentin bound to both DRB1*04:01 and *04:02, while native vimentin bound only to *04:02.”
BackgroundBadillo-Soto, M. A., Rodríguez-Rodríguez, M., Pérez, M. E. P., Daza-Benítez, L., Bollain-y-Goytia, J. J., Jiménez, M. A. C., Ávalos-Díaz, E., & Esparza, R. H. (2016) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2015.0055 · Cited by 25
Jung, N., Bueb, J., Tolle, F., & Bréchard, S. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.010 · Cited by 25
Bécart, S., Whittington, K. B., Prislovsky, A., Rao, N. L., & Rosloniec, E. F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245541 · Cited by 25
“While the MHC-II alleles expressing the SE appear to have some propensity to accommodate a citrulline at the P4 position for peptide binding [20, 21], our data and others [35] indicate that this is not a universal phenomenon of citrullinated antigenic peptides.”
BackgroundEmploying proteomics in the study of antigen presentation: an update
Ramarathinam, S. H., Croft, N. P., Illing, P. T., Faridi, P., & Purcell, A. W. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1509000 · Cited by 25
Self-citationErratum: Autophagy: controlling cell fate in rheumatic diseases
Rockel, J. S., & Kapoor, M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.17 · Cited by 25
Carlé, C., Degboé, Y., Ruyssen‐Witrand, A., Arleevskaya, M. I., Clavel, C., & Renaudineau, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054296 · Cited by 24
“Moreover, high-affinity autoreactive CD4+ T cell expansion is related to memory T cells, and their level is correlated with disease activity and ACPA level [84,88,101].”
BackgroundBrentville, V. A., Symonds, P., Cook, K. W., Daniels, I., Pitt, T., Gijon, M., Vaghela, P., Xue, W., Shah, S., Metheringham, R. L., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1576490 · Cited by 21
The KAG Motif of HLA-DRB1 (β71, β74, β86) Predicts Seroconversion and Development of Type 1 Diabetes
Zhao, L. P., Papadopoulos, G. K., Lybrand, T. P., Moustakas, A. K., Bondinas, G. P., Carlsson, A., Larsson, H. E., Ludvigsson, J., Marcus, C., Persson, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103431 · Cited by 23
Shared lung and joint T cell repertoire in early rheumatoid arthritis driven by cigarette smoking
Venken, K., Jarlborg, M., Stevenaert, F., Malfait, T. L. A., Vlieghe, C., Abraham, Y., Manuello, T., Decruy, T., Vanhee, S., Wils, H., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-226284 · Cited by 23
Shoda, H., Hanata, N., Sumitomo, S., Okamura, T., Fujio, K., & Yamamoto, K. (2016) · Scientific Reports · doi:10.1038/srep22486 · Cited by 23
Jansen, M. A. A., Spiering, R., Broere, F., van Laar, J. M., Isaacs, J. D., van Eden, W., & Hilkens, C. M. U. (2017) · Immunology · doi:10.1111/imm.12811 · Cited by 23
“54 57 – 59 They also showed that in the autoantigen recognizing CD4 + T-cell population of HLA-DRB1*04:01 + RA patients, the percentage Treg cells (both activated and resting) was reduced, whereas the populations of naive and effector memory CD4 + T cells were increased compared with healthy…”
Citrullination in Rheumatoid Arthritis—A Process Promoted by Neutrophil Lysis?
Gazitt, T., Lood, C., & Elkon, K. B. (2016) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10254 · Cited by 23
The avian major histocompatibility complex
Kaufman, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818708-1.00033-6 · Cited by 23
Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapy
Nel, H. J., Malmström, V., Wraith, D. C., & Thomas, R. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30344-1 · Cited by 22
Self-citationPaulín, F., Babini, A. M., Mamani, M. N., Mercado, J. F., & Caro, F. M. (2017) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.17002162 · Cited by 22
Is rheumatoid arthritis an autoimmune disease?
Chemin, K., Klareskog, L., & Malmström, V. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000253 · Cited by 21
“of the HLA-DRB1 04 : 01 and 04 : 04 molecules [57].”
Sandalova, T., Sala, B. M., & Achour, A. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.861609 · Cited by 21
“Structural studies have demonstrated that citrullination of an arginine residue at p4 can result in the creation of a neo-selfantigen since this PTMmakes it possible for the modified epitope to bind to HLA-DRB1*0401 or HLA-DRB1*0101, while the wildtype peptide cannot (Figure 4A) (Ting et al., 2018).”
BackgroundInfluentialSpurlock, C. F., Tossberg, J. T., Olsen, N. J., & Aune, T. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500267 · Cited by 21
“The molecular basis for this association may be preferred binding of MHC class II molecules encoded by HLA-DRB1*04 to citrullinated rather than arginine-containing peptides (4).”
BackgroundSuurmond, J., Zou, Y. R., Kim, S. J., & Diamond, B. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3809 · Cited by 21
Peptide‐Based Vaccination Therapy for Rheumatic Diseases
Wang, B., Chen, S., Zheng, Q., Liu, Y., & Shi, G. (2020) · Journal of Immunology Research · doi:10.1155/2020/8060375 · Cited by 21
“Recent studies reveal that central tolerance mediated by negative selection can prune but not completely eliminate autoreactive T cells, which leads to the incomplete negative selection and the existence of autoreactive T cells in the circulating system among healthy individuals [82 – 85].”
Whitmore, E. K., Martin, D., & Guvench, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207699 · Cited by 21
Can autoimmune disease be cured by deep CD19+ cell depletion?
Suan, D., Moore, J., & Goodnow, C. C. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf008 · Cited by 20
Jansen, D. T. S. L., Ramnoruth, N., Loh, K. L., Rossjohn, J., Reid, H. H., Nel, H. J., & Thomas, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00008 · Cited by 20
“Alternative published approaches include the tyrosine kinase inhibitor dasatinib, to reduce TCR internalization and maximize TCR surface detection, and amplification of the tetramer signal using an antibody sandwich (7, 8, 14).”
InfluentialSelf-citationLac, P., Saunders, S., Tutunea-Fatan, E., Barra, L., Bell, D., & Cairns, E. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.002 · Cited by 20
Sakkas, L. I., & Bogdanos, D. P. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000503 · Cited by 20
Sapir‐Koren, R., & Livshits, G. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.05.009 · Cited by 20
Patient HLA Germline Variation and Transplant Survivorship
Petersdorf, E. W., Stevenson, P. A., Malkki, M., Strong, R. K., Spellman, S. R., Haagenson, M. D., Horowitz, M. M., Gooley, T. A., & Wang, T. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6534 · Cited by 19
Nagafuchi, Y., Ota, M., Hatano, H., Inoue, M., Kobayashi, S., Okubo, M., Sugimori, Y., Nakano, M., Yamada, S., Yoshida, R., et al. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102907 · Cited by 18
Kassardjian, A., Sun, E., Sookhoo, J. R. V., Muthuraman, K., Boligan, K. F., Kucharska, I., Rujas, E., Jetha, A., Branch, D. R., Babiuk, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112391 · Cited by 18
Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis
Maggi, J., Carrascal, M., Soto, L., Neira, O. J., Cuéllar‐Gutiérrez, M. C., Aravena, O., James, E. A., Abián, J., Jaraquemada, D., Catalán, D., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220371 · Cited by 18
Regueiro, C., Rodríguez‐Rodríguez, L., Triguero‐Martínez, A., Nuño, L., Núñez, Á. L. C., Villalva, A., Pérez-Pampín, E. M., Lopez-Golan, Y., Abásolo, L., Ortiz, A. M., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40738 · Cited by 18
“Once the citrullinated peptides are bound by the SE, the peptide–HLA complex is presented to specific autoreactive T cells as an initial step in the autoimmune process (8,9).”
BackgroundUncovering a Shared Epitope–Activated Protein Citrullination Pathway
van Drongelen, V., Ali, W. H., & Holoshitz, J. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901108 · Cited by 18
“The prevailing hypotheses postulate that the SE allows the presentation of putative self or foreign arthritogenic Ags (10) or Cit proteins (11) to T lymphocytes, which help B cells to produce autoantibodies, such as ACPA (discussed in Ref.”
BackgroundMolecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes
Nakayama, M., Simmons, K. M., & Michels, A. W. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0689-z · Cited by 18
Crystal structure of the human LAG-3–HLA-DR1–peptide complex
Petersen, J., Llerena, C., Golzarroshan, B., Faoro, C., Triebel, F., & Rossjohn, J. (2024) · Science Immunology · doi:10.1126/sciimmunol.ads5122 · Cited by 17
“…exchange in HLA-DR1 CLIP and HLA-DP4 CLIP with synthetic peptides MART1 and S 167-180 , respectively was performed in the presence of HLA-DM as previously described ( 36, 50 ). were expressed in Hi5 insect cells with the peptide covalently linked to the N-terminus of the HLA-DQ β-chain ( 37, 41 ).”
Self-citationXia, L., Chen, M., Zhang, H., Zheng, X., Bao, J., Gao, J., Zhu, C., Sun, L., Xia, H., & Zhang, X. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24457 · Cited by 17
Rheumatoid arthritis and the biological clock
Cata, A. D., D’Agruma, L., Tarquini, R., & Mazzoccoli, G. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.899904 · Cited by 17
“A key pathophysiological role is played by cytokines, such as TNF-a, IL-1, IL-6, IL-15 and IL-17, T and B lymphocytes and autoantibodies such as IgM rheumatoid factor and anti-cyclic citrullinated peptide antibodies [2–6].”
BackgroundTimofeeva, A. M., Aulova, K. S., Mustaev, E. A., & Nevinsky, G. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188793 · Cited by 16
“For example, HLA-DRB1*04:01, 04:04, 04:05, and 01:01 alleles are associated with susceptibility to rheumatoid arthritis [190–193].”
Post-translational modifications of proteins in antiphospholipid antibody syndrome
Buttari, B., Profumo, E., Capozzi, A., Saso, L., Sorice, M., & Riganò, R. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1650714 · Cited by 16
“Exposure of neoepitopes to the immune system [108,109] [110]”
BackgroundMusaelyan, A. A., Lapin, S. V., Urtenova, M., Odintsova, S., Chistyakov, I., Ulitin, A. M., Akopov, A. L., & Orlov, S. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11495 · Cited by 16
“HLA class II molecules play a role in cross‐priming, T and B cell modula‐ tion, and the development of autoimmunity (16).”
BackgroundUpdate on Autoimmune Diseases Pathogenesis
Kechida, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190709205421 · Cited by 16
14-3-3ζ-A Novel Immunogen Promotes Inflammatory Cytokine Production
McGowan, J., Peter, C., Chattopadhyay, S., & Chakravarti, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01553 · Cited by 16
“Here, we utilized specialized T2 (class II-deficient) cells co-expressing either vector control or HLA-DRB1∗0401 (with HLA-DM) (34) to test their effect on 14-3-3ζ-induced cytokine production.”
MethodImpact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition
Szeto, C. W., Bloom, J., Sloane, H., Lobos, C. A., Fodor, J., Jayasinghe, D., Chatzileontiadou, D. S. M., Grant, E. J., Buckle, A. M., & Gras, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197081 · Cited by 16
Scholz, E., Mestre‐Ferrer, A., Daura, X., García‐Medel, N., Carrascal, M., James, E. A., Kwok, W. W., Canals, F., & Álvarez, I. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39736 · Cited by 15
“The anchor motifs of HLA–DRB1*04:01, HLA–DRB1*04:02, and HLA–DRB1*04:04 have been identified based on peptide ligands (37), although the overlap of the repertoires was not described.”
BackgroundIndonesians Human Leukocyte Antigen (HLA) Distributions and Correlations with Global Diseases
Pradana, K. A., Widjaya, M. A., & Wahjudi, M. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1673771 · Cited by 15
HLA and anti-citrullinated protein antibodies: Building blocks in RA
van der Woude, D., & Catrina, A. I. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.02.006 · Cited by 15
Ding, Y., Luo, H., & Qi, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1684-0 · Cited by 15
Garrido‐Mesa, J., & Brown, M. A. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01218-9 · Cited by 14
“182) and its interaction with citrullinated peptides 183 .”
Symonds, P., Marcu, A., Cook, K., Metheringham, R. L., Durrant, L. G., & Brentville, V. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.764462 · Cited by 14
“RA is mainly restricted to individuals expressing shared HLA-DR alleles (39).”
BackgroundImmuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis
Mondal, S., Saha, S., & Sur, D. (2024) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2024.2330636 · Cited by 14
“Polymorphism at the N terminal region (between 70 and 74) of the HlA-DRB gene borders the repertoire of epitopes. therefore, the Activation of t cells by MHc-ii is considered one of the major events of RA pathogenesis [27].”
BackgroundRoark, C. L., Anderson, K. M., Aubrey, M. T., Rosloniec, E. F., & Freed, B. M. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.04.006 · Cited by 14
New Relationships for Old Autoantibodies in Rheumatoid Arthritis
Shelef, M. A. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40879 · Cited by 14
“The enhanced binding of shared epitope–containing MHC class II molecules to citrullinecontaining peptides likely contributes to this pathology (8).”
BackgroundBalakrishnan, S., Kumar, P., & Prabhakar, B. S. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140478 · Cited by 14
Future molecular medicine from white frangipani (Plumeria alba L.): A review
Barry, A., Enade, I., & Hariono, M. (2020) · Journal of Medicinal Plants Research · doi:10.5897/jmpr2020.6947 · Cited by 14
Law, S. C., Benham, H., Reid, H. H., Rossjohn, J., & Thomas, R. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.07.015 · Cited by 14
Self-citationvan Heemst, J., Huizinga, T. W. J., van der Woude, D., & Toes, R. E. M. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000165 · Cited by 14
“All rights rese the HLA alleles that do not predispose to ACPApositive disease, to present citrullinated epitopes [7,8].”
BackgroundSelf-citationNew insights into the understanding of MHC associations with immune‐mediated disorders
Caillat‐Zucman, S. (2016) · HLA · doi:10.1111/tan.12947 · Cited by 14
“(35) elegantly showed how citrullinated aggrecan and vimentin epitopes bind to HLA-DRB1*04:01/04.”
BackgroundPADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis
Hisa, K., Yanagimachi, M. D., Naruto, T., Miyamae, T., Kikuchi, M., Hara, R., Imagawa, T., Yokota, S., & Mori, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171961 · Cited by 14
Tran, M. T., Lim, J. J., Loh, T. J., Mannering, S. I., Rossjohn, J., & Reid, H. H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107612 · Cited by 13
Self-citationGómez-Bañuelos, E., Konig, M. F., & Andrade, F. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102423 · Cited by 13
Restoring Balance: Immune Tolerance in Rheumatoid Arthritis
Kaur, J., Cairns, E., & Barra, L. (2023) · The Journal of Rheumatology · doi:10.3899/jrheum.220881 · Cited by 13
Do we need a new classification of juvenile idiopathic arthritis?
Rosenberg, A. M. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.108298 · Cited by 13
HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema
Shi, Y., Wang, J., Min, F., Bian, W., Mao, B.-J., Mao, Y., Qin, B., Li, B.-M., Ou, Y.-M., Hou, Y., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671572 · Cited by 13
“For HLA-DR, the protein structure of HLA-DRB1*01:01 and HLA-DRB1*04:01 have been identified experimentally (Gunther et al., 2010; Scally et al., 2013) and are risk-free molecules.”
BackgroundWhittingham, S., Stockman, A., & Rowley, M. J. (2017) · Antibodies · doi:10.3390/antib6020006 · Cited by 13
“0122), consistent with the reported linkage between the SE and enhanced antigen presentation of citrullinated peptides [31].”
BackgroundMachaj, F., Rosik, J., Szostak, B., & Pawlik, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1682992 · Cited by 13
Antigen presentation of post‐translationally modified peptides in major histocompatibility complexes
de Wit, A. S., Bianchi, F., & van den Bogaart, G. (2025) · Immunology & Cell Biology · doi:10.1111/imcb.12839 · Cited by 12
Huisman, B. D., Balivada, P. A., & Birnbaum, M. E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102913 · Cited by 12
“We performed selections with HLA-DR401, as illustrated in Figure 1D, which would enable comparison with existing pMHC-II datasets (4, 14, 15).”
MethodPhotopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept
Coppard, C., Bonnefoy, F., Hannani, D., Gabert, F. M., Manches, O., Plumas, J., Perruche, S., & Chaperot, L. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2066-1 · Cited by 12
Trejo‐Zambrano, M. I., Gómez-Bañuelos, E., & Andrade, F. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0064 · Cited by 12
“…of anticitrullinated protein antibodies (ACPAs) enlightened the striking association between RA and HLA-DRB1 shared epitope (SE) alleles (87), suggesting that this association is driven through the presentation of citrullinated antigens by molecules encoded by HLA-DRB1-SE alleles (145, 173).”
Amaral-Silva, D., Gonçalves, R., Torrão, R. C., Torres, R. P., Falcão, S., Gonçalves, M. J., Araújo, M. P., Martins, M. J., Lopes, C. A., Neto, A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02659-0 · Cited by 12
Hemon, M. F., Lambert, N. C., Arnoux, F., Roudier, J., & Auger, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840035 · Cited by 12
“showed the structure of Vim R70Cit bound to HLADRB1*04:01, *04:04 and HLA-DRB1*04:02, the latter unexpected since HLA-DRB1*04:02 does not contain the shared epitope and is not associated with RA (14).”
BackgroundAtlas of human diseases influenced by genetic variants with extreme allele frequency differences
Sulovari, A., Chen, Y. H., Hudziak, J. J., & Li, D. (2016) · Human Genetics · doi:10.1007/s00439-016-1734-y · Cited by 11
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis
Mulinacci, G., Palermo, A., Gerussi, A., Asselta, R., Gershwin, M. E., & Invernizzi, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.975115 · Cited by 11
“Frontiers in Immunology 09 of certain HLA haplotypes are responsible for the presentation of citrullinated peptides, recognized as non-self by T cells (92).”
BackgroundTherapeutic potential and recent progression of BTK inhibitors against rheumatoid arthritis
Paliwal, S., Bawa, S., Shalmali, N., & Tonk, R. K. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14582 · Cited by 10
Moustakas, A. K., Nguyen, H. Q. T., James, E. A., & Papadopoulos, G. K. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104729 · Cited by 10
Unraveling Desmin’s Head Domain Structure and Function
Vlachakis, D. P., Tsilafakis, K., Kostavasili, I., Κοσσίδα, Σ., & Mavroidis, M. (2024) · Cells · doi:10.3390/cells13070603 · Cited by 10
“Also, two short overlapping fragments of the vimentin head domain (residues 59–71 and 66–78) have been crystallized recently, when bound to a human leukocyte antigen (PDB codes 4MD0 and 4MDJ) [71].”
BackgroundOkada, N., Oshima, K., Maruko, A., Sekine, M., Ito, N., Wakasugi, A., Mori, E., Odaguchi, H., & Kobayashi, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1450708 · Cited by 10
Genetic Predisposition to Autoimmune Diseases Conferred by the Major Histocompatibility Complex
Taneja, V., Mangalam, A. K., & David, C. S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00027-7 · Cited by 10
Anand, S., Littler, D. R., Mobbs, J. I., Braun, A., Baker, D. G., Tennant, L., Purcell, A. W., Vivian, J. P., & Rossjohn, J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104930 · Cited by 10
“The presentation of citrullinated self-epitopes by HLA-DRB1*04:01/04 may contribute to rheumatoid arthritis (14, 15).”
BackgroundSelf-citationRuyssen‐Witrand, A., van Steenbergen, H. W., van Heemst, J., Gourraud, P., Nigon, D., Lukas, C., Miceli‐Richard, C., Jamard, B., Cambon‐Thomsen, A., Cantagrel, A. G., et al. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000099 · Cited by 10
Hirsiger, J. R., Tamborrini, G., Harder, D., Bantug, G. R., Höenger, G., Recher, M., Marx, C., Li, Q., Martín, I., Hess, C., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102714 · Cited by 10
Sun, R., Wang, Y., & Abolhassani, H. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2208863 · Cited by 9
“For example, HLA-DR4 associated with Rheumatoid arthritis due to abnormal post-translational modification results in citrullination of in RA patients autoantigens [23,24].”
BackgroundA review of CD4+ T cell differentiation and diversity in dogs
Lang, H. P., Osum, K. C., & Friedenberg, S. G. (2024) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2024.110816 · Cited by 9
Tibbitt, C. A., Falconer, J., Stoop, J. N., van Eden, W., Robinson, J. H., & Hilkens, C. M. U. (2016) · European Journal of Immunology · doi:10.1002/eji.201546217 · Cited by 9
Raslan, H. M., Attia, H., Ibrahim, M. H., Hassan, E. M., Salama, I. I., Ismail, S., Bayomi, E. A., Menyawi, M. E., & Amr, K. S. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13819 · Cited by 9
Cook, K., Xue, W., Atabani, S., Symonds, P., Al‐Omari, A., Daniels, I., Shah, S., Choudhury, R., Weston, D., Metheringham, R. L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.873947 · Cited by 9
Successes, challenges and developments in Australian rheumatology
Morand, E. F., & Leech, M. T. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.22 · Cited by 9
Nitration of MOG diminishes its encephalitogenicity depending on MHC haplotype
Warnecke, A., Musunuri, S., N’diaye, M., Sandalova, T., Achour, A., Bergquist, J., & Harris, R. A. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.11.008 · Cited by 9
Cope, A. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00052-1 · Cited by 9
The molecular basis of T cell receptor recognition of citrullinated tenascin-C presented by HLA-DR4
Dao, H. T., Loh, T. J., Sharma, R. K., Klareskog, L., Malmström, V., Reid, H. H., Rossjohn, J., & Lim, J. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110326 · Cited by 8
“…established binding motif of previously reported HLA-DRB1*04:01 presenting fi brinogen b 74cit69-81 and vimentin 64cit59-71 peptides, where the P1 pocket accommodated by a tyrosine residue, and the P4 pocket was occupied with a neutral asparagine or citrulline residue, respectively (13, 14) (Fig.”
Self-citationRheumatoid arthritis — the role of T cells in this complex systemic autoimmune disease
Savvides, C. S., James, E. A., & Buckner, J. H. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102555 · Cited by 8
Functional Genetics to Understand the Etiology of Autoimmunity
Hatano, H., & Ishigaki, K. (2023) · Genes · doi:10.3390/genes14030572 · Cited by 8
“reported the structural basis of how the risk HLA-DB1 alleles enhance an autoimmune reaction to the citrullinated epitopes, focusing on two HLA risk alleles (HLA-DRB1*04:01 and 04:04) with an electropositive P4 antigen-binding pocket and a protective allele (HLA-DRB1*04:02) with an electronegative P4 pocket [20].”
The complex relationship between large granular lymphocyte leukemia and rheumatic disease
Marchand, T., & Lamy, T. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2292758 · Cited by 8
“The human class II MHC, especially some HLA-DR alleles represent a predisposing factor to several rheumatic disorders including RA, systemic lupus erythematosus, Sjogren’s Syndrome, and vasculitis [119,120].”
BackgroundBitoun, S., Roques, P., Larcher, T., Nocturne, G., Serguera, C., Chrétien, P., Serre, G., Grand, R. L., & Mariette, X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01816 · Cited by 8
“This could be considered surprising given what is usually admitted that there is a better presentation of citrullinated peptides by the shared epitope However, this assumption based on only two studies (3, 5) is still debated.”
BackgroundMethodDasariraju, S., Gragert, L. A., Wager, G. L., McCullough, K. P., Brown, N. K., Kamoun, M., & Urbanowicz, R. J. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104374 · Cited by 8
Posttranslationally modified self-peptides promote hypertension in mouse models
Bloodworth, N. C., Chen, W., Hunter, K., Patrick, D. M., Palubinsky, A. M., Phillips, E. J., Roeth, D., Kalkum, M., Mallal, S. A., Davies, S. S., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174374 · Cited by 7
Baglaenko, Y., Wagner, C. A., Bhoj, V. G., Brodin, P., Gershwin, M. E., Graham, D. B., Invernizzi, P., Kídd, K. K., Korsunsky, I., Levy, M., et al. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.14 · Cited by 7
“…or peptide – MHC tetramers revealed Th1 and Th17 reactivity to citrullinated antigens, including α -enolase, fibrinogen, vimentin, and aggrecan, in the peripheral blood of patients with RA (Delwig et al., 2010; Law et al., 2012; Scally et al., 2013; James et al., 2014; Gerstner et al., 2020).”
BackgroundTumor antigen presentation and the associated signal transduction during carcinogenesis
Naskar, S., Sriraman, N., Sarkar, A., Mahajan, N., & Sarkar, K. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155485 · Cited by 7
Bitoun, S., Roques, P., Maillère, B., Grand, R. L., & Mariette, X. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215114 · Cited by 7
Metadata
- Authors
- Scally, S. W., Petersen, J., Law, S. C., Dudek, N. L., Nel, H. J., Loh, K. L., Wijeyewickrema, L. C., Eckle, S. B. G., van Heemst, J., Pike, R. N., McCluskey, J., Toes, R. E., La Gruta, N. L., Purcell, A. W., Reid, H. H., Thomas, R., & Rossjohn, J.
- Affiliations
- Monash University (AU)
- Translational Research Institute (AU)
- The University of Melbourne (AU)
- Department of Rheumatology, Leiden University Medical Center, 2300 RC Leiden, Netherlands 4
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia 3
- Corresponding author
- Purcell, Anthony W.
- Reid, Hugh H.
- Thomas, Ranjeny
- Rossjohn, Jamie
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-11-04
- Volume
- 210
- Issue
- 12
- Pages
- 2569-2582
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3832918
- OpenAlex
- W2146707828
- Cited by
- 429
- References
- 59
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 27 · 2023: 42 · 2022: 25 · 2021: 31 · 2020: 33 · 2019: 41 · 2018: 36 · 2017: 41 · 2016: 48 · 2015: 35 · 2014: 25 · 2013: 1
- FWCI
- 29.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- rheumatoid arthritis, HLA-DRB1, citrullination, citrullinated vimentin, HLA-DRB1*0401, peptide binding, autoreactive T cells, CD4+ T cells, regulatory T cells, disease activity, autoantigens
- MeSH terms
- Amino Acid Sequence, Animals, Epitopes, Arthritis, Rheumatoid, Autoantigens, Citrulline, Humans, Mice, Transgenic, Models, Molecular, Molecular Sequence Data, Polymorphism, Genetic, Vimentin, CD4-Positive T-Lymphocytes, HLA-DR4 Antigen, Antigen Presentation, Mice, Aggrecans, Genetic Association Studies, HLA-DR beta-Chains, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.